Syngen Biotech Co.,Ltd. (TPEX:8279)

Accolade Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	222.83	341.93	366.89	246.05	314.8	423.42
Cash & Short-Term Investments	222.83	341.93	366.89	246.05	314.8	423.42
Cash Growth	-17.65%	-6.80%	49.11%	-21.84%	-25.65%	-18.48%
Accounts Receivable	574.92	422.56	387.8	472.06	388.16	298.71
Other Receivables	0	0	0	0	0	-
Receivables	574.92	422.56	387.8	472.06	388.16	298.71
Inventory	368.49	345.62	348.99	369.35	291.96	259.78
Prepaid Expenses	36.02	44.93	28.77	25.42	23.17	34.92
Total Current Assets	1,202	1,155	1,132	1,113	1,018	1,017
Property, Plant & Equipment	1,492	1,518	1,526	1,543	1,035	1,035
Long-Term Investments	325.81	324.34	331.74	313.75	293.55	2.7
Other Intangible Assets	37.53	27.57	24.13	22.96	23.42	27.32
Long-Term Deferred Tax Assets	17.68	18.86	17.44	16.21	12.32	10.39
Other Long-Term Assets	52.22	38.4	73.21	58.7	28.23	28.94
Total Assets	3,128	3,085	3,106	3,071	2,416	2,127
Accounts Payable	276.82	255.87	226.47	248.45	236.86	140.59
Accrued Expenses	-	78.84	72.8	79.89	64.72	3.94
Short-Term Debt	-	-	80	230	-	50
Current Portion of Long-Term Debt	59.03	59.03	59.03	-	-	-
Current Portion of Leases	15.13	14.71	13.38	14.85	13.7	14.11
Current Income Taxes Payable	37.65	35.18	62.06	76.99	58.39	28.12
Current Unearned Revenue	31.81	24.83	20.04	6.73	6.55	1.97
Other Current Liabilities	267.45	51.7	50.81	62.56	38.4	73.27
Total Current Liabilities	687.88	520.16	584.58	719.47	418.61	312
Long-Term Debt	34.43	163.95	222.97	182	50	-
Long-Term Leases	153.66	160.25	163.1	173.93	172.39	186.17
Long-Term Deferred Tax Liabilities	3.23	4.17	3.98	3.93	3.16	2.58
Total Liabilities	879.21	848.52	974.63	1,079	644.16	500.74
Common Stock	271.01	271.01	271.01	271.01	271.01	271.01
Additional Paid-In Capital	610.94	618.24	618.2	618.06	612.83	610.54
Retained Earnings	1,357	1,344	1,243	1,103	887.88	744.67
Comprehensive Income & Other	9.38	2.73	-0.26	-0.07	-0.36	-0.12
Shareholders' Equity	2,249	2,236	2,132	1,992	1,771	1,626
Total Liabilities & Equity	3,128	3,085	3,106	3,071	2,416	2,127
Total Debt	262.25	397.93	538.49	600.78	236.08	250.28
Net Cash (Debt)	-39.42	-56	-171.6	-354.73	78.72	173.14
Net Cash Growth	-	-	-	-	-54.53%	-52.69%
Net Cash Per Share	-1.45	-2.06	-6.33	-13.07	2.90	6.38
Filing Date Shares Outstanding	27.1	27.1	27.1	27.1	27.1	27.1
Total Common Shares Outstanding	27.1	27.1	27.1	27.1	27.1	27.1
Working Capital	514.37	634.89	547.87	393.41	599.48	704.84
Book Value Per Share	82.96	82.51	78.66	73.49	65.36	60.00
Tangible Book Value	2,211	2,209	2,107	1,969	1,748	1,599
Tangible Book Value Per Share	81.58	81.49	77.76	72.64	64.50	58.99
Land	-	251	251	251	-	-
Buildings	-	729.7	717.09	702.28	532.98	529.5
Machinery	-	1,022	871.44	841.51	693.37	656.19
Construction In Progress	-	74.67	146.33	114.01	111.97	79.98

Source: S&P Global Market Intelligence. Standard template. Financial Sources.